Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SASANLIMAB for Bladder transitional cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where SASANLIMAB was used for Bladder transitional cell carcinoma.

Other Indications for SASANLIMAB

Non-small cell lung cancer (15) Bladder cancer (7)

Other Drugs Used for Bladder transitional cell carcinoma

GEMCITABINE (335) CISPLATIN (252) PEMBROLIZUMAB (251) ATEZOLIZUMAB (195) CARBOPLATIN (146) BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (119) AVELUMAB (104) DURVALUMAB (88) NIVOLUMAB (80) ENFORTUMAB VEDOTIN-EJFV (68)

Related Pages

SASANLIMAB Full Profile All Bladder transitional cell carcinoma Drugs SASANLIMAB Demographics SASANLIMAB Timeline